These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 38071554)
41. Assessment of the novel estrogen receptor PET tracer 4-fluoro-11β-methoxy-16α-[(18)F]fluoroestradiol (4FMFES) by PET imaging in a breast cancer murine model. Paquette M; Phoenix S; Ouellet R; Langlois R; van Lier JE; Turcotte EE; Bénard F; Lecomte R Mol Imaging Biol; 2013 Oct; 15(5):625-32. PubMed ID: 23619898 [TBL] [Abstract][Full Text] [Related]
42. A Randomized Feasibility Study of Chae SY; Kim SB; Ahn SH; Kim HO; Yoon DH; Ahn JH; Jung KH; Han S; Oh SJ; Lee SJ; Kim HJ; Son BH; Gong G; Lee HS; Moon DH J Nucl Med; 2017 Apr; 58(4):563-568. PubMed ID: 27688475 [TBL] [Abstract][Full Text] [Related]
43. The preliminary study of 16α-[18F]fluoroestradiol PET/CT in assisting the individualized treatment decisions of breast cancer patients. Sun Y; Yang Z; Zhang Y; Xue J; Wang M; Shi W; Zhu B; Hu S; Yao Z; Pan H; Zhang Y PLoS One; 2015; 10(1):e0116341. PubMed ID: 25617853 [TBL] [Abstract][Full Text] [Related]
45. Kumar M; Salem K; Michel C; Jeffery JJ; Yan Y; Fowler AM J Nucl Med; 2019 Sep; 60(9):1247-1252. PubMed ID: 30850489 [TBL] [Abstract][Full Text] [Related]
46. Estrogen Receptor-Targeted and Progesterone Receptor-Targeted PET for Patients with Breast Cancer. Ulaner GA; Fowler AM; Clark AS; Linden H PET Clin; 2023 Oct; 18(4):531-542. PubMed ID: 37270377 [TBL] [Abstract][Full Text] [Related]
47. Evaluation of tumour heterogeneity by Liu C; Hu S; Xu X; Zhang Y; Wang B; Song S; Yang Z Breast Cancer Res; 2022 Aug; 24(1):57. PubMed ID: 36028895 [TBL] [Abstract][Full Text] [Related]
48. Functional images reflect aggressiveness of endometrial carcinoma: estrogen receptor expression combined with 18F-FDG PET. Tsujikawa T; Yoshida Y; Kudo T; Kiyono Y; Kurokawa T; Kobayashi M; Tsuchida T; Fujibayashi Y; Kotsuji F; Okazawa H J Nucl Med; 2009 Oct; 50(10):1598-604. PubMed ID: 19759112 [TBL] [Abstract][Full Text] [Related]
49. 18F-Fluoroestradiol Tumor Uptake Is Influenced by Structural Components in Breast Cancer. Takahashi M; Maeda H; Tsujikawa T; Kono H; Mori T; Kiyono Y; Okazawa H; Noriki S; Imamura Y; Goi T Clin Nucl Med; 2021 Nov; 46(11):884-889. PubMed ID: 34319950 [TBL] [Abstract][Full Text] [Related]
50. Comparison of diagnostic sensitivity of [ Chae SY; Son HJ; Lee DY; Shin E; Oh JS; Seo SY; Baek S; Kim JY; Na SJ; Moon DH EJNMMI Res; 2020 May; 10(1):54. PubMed ID: 32448947 [TBL] [Abstract][Full Text] [Related]
51. Longitudinal Molecular Imaging of Progesterone Receptor Reveals Early Differential Response to Endocrine Therapy in Breast Cancer with an Activating Kumar M; Salem K; Jeffery JJ; Yan Y; Mahajan AM; Fowler AM J Nucl Med; 2021 Apr; 62(4):500-506. PubMed ID: 32859700 [TBL] [Abstract][Full Text] [Related]
52. 18F-Fluoroestradiol Positron Emission Tomography in Breast Cancer Patients: Systematic Review of the Literature & Meta-Analysis. Evangelista L; Guarneri V; Conte PF Curr Radiopharm; 2016; 9(3):244-257. PubMed ID: 27774910 [TBL] [Abstract][Full Text] [Related]
53. Salem K; Kumar M; Powers GL; Jeffery JJ; Yan Y; Mahajan AM; Fowler AM Radiology; 2018 Mar; 286(3):856-864. PubMed ID: 28956736 [TBL] [Abstract][Full Text] [Related]
54. Xu D; Zhuang R; You L; Guo Z; Wang X; Peng C; Zhang D; Zhang P; Wu H; Pan W; Zhang X Nucl Med Biol; 2018 Apr; 59():48-55. PubMed ID: 29466767 [TBL] [Abstract][Full Text] [Related]
55. The Predictive Value of Early Changes in He M; Liu C; Shi Q; Sun Y; Zhang Y; Xu X; Yuan H; Zhang Y; Liu Y; Liu G; Di G; Yang Z; Wang Z; Shao Z Oncologist; 2020 Nov; 25(11):927-936. PubMed ID: 32272493 [TBL] [Abstract][Full Text] [Related]
56. Cross-Species Physiological Assessment of Brain Estrogen Receptor Expression Using Paquette M; Phoenix S; Lavallée É; Rousseau JA; Guérin B; Turcotte ÉE; Lecomte R Mol Imaging Biol; 2020 Oct; 22(5):1403-1413. PubMed ID: 32699974 [TBL] [Abstract][Full Text] [Related]
58. PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer. Dehdashti F; Mortimer JE; Trinkaus K; Naughton MJ; Ellis M; Katzenellenbogen JA; Welch MJ; Siegel BA Breast Cancer Res Treat; 2009 Feb; 113(3):509-17. PubMed ID: 18327670 [TBL] [Abstract][Full Text] [Related]
59. Prospective Pilot Study of Covington MF; Hoffman JM; Morton KA; Buckway B; Boucher KM; Rosenthal RE; Porretta JM; Brownson KE; Matsen CB; Vaklavas C; Ward JH; Wei M; Buys SS; Chittoria N; Yakish ED; Archibald ZG; Burrell LD; Butterfield RI; Yap JT AJR Am J Roentgenol; 2023 Aug; 221(2):228-239. PubMed ID: 36919879 [No Abstract] [Full Text] [Related]
60. PET imaging of oestrogen receptors in patients with breast cancer. van Kruchten M; de Vries EGE; Brown M; de Vries EFJ; Glaudemans AWJM; Dierckx RAJO; Schröder CP; Hospers GAP Lancet Oncol; 2013 Oct; 14(11):e465-e475. PubMed ID: 24079874 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]